#findings offer clinicians practical way to choose next antibody-drug conjugate treatment after progression

UH researchers find drug resistance not end of line for cancer patients

University of Hawaiʻi researchers found that switching the type of drug attached to the antibody in breast cancer treatments could restore benefit after resistance.